We are live on ! Find out more
EAM

Exane Asset Management Portfolio holdings

AUM $277M
1-Year Est. Return 26.27%
This Fund
S&P 500
This Quarter Est. Return
+5.81%
1 Year Est. Return
+26.27%
3 Year Est. Return
+77.5%
5 Year Est. Return
+80.92%
10 Year Est. Return
+419.8%
AUM
$225M
AUM Growth
+$19.6M
Cap. Flow
+$21.9M
Cap. Flow %
9.72%
Top 10 Hldgs %
53.35%
Holding
65
New
24
Increased
14
Reduced
9
Closed
15

Sector Composition

1 Healthcare 29.75%
2 Materials 23.81%
3 Communication Services 14.14%
4 Technology 10.44%
5 Industrials 8.5%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DD icon
1
DuPont de Nemours
DD
$18.2B
$21.7M 9.63%
230,007
+95,041
+70% +$11.3M
ASH icon
2
Ashland
ASH
$3.13B
$18.7M 8.29%
+233,279
New +$18M
QGEN icon
3
Qiagen
QGEN
$8.46B
$12.7M 5.62%
+293,973
New +$12.2M
RHT
4
DELISTED
Red Hat Inc
RHT
$12.5M 5.55%
66,586
+11,086
+20% +$2.05M
CELG
5
DELISTED
Celgene Corp
CELG
$10.9M 4.82%
117,400
+70,800
+152% +$6.72M
BMY icon
6
Bristol-Myers Squibb
BMY
$124B
$10.7M 4.74%
235,470
-78,425
-25% -$3.65M
APC
7
DELISTED
Anadarko Petroleum
APC
$9.53M 4.23%
+135,000
New +$9.05M
T icon
8
AT&T
T
$151B
$9.19M 4.08%
362,936
-78,911
-18% -$1.89M
LYB icon
9
LyondellBasell Industries
LYB
$19.1B
$7.95M 3.53%
+92,251
New +$7.87M
TIMB icon
10
TIM SA
TIMB
$10.5B
$6.42M 2.85%
428,549
-360,274
-46% -$5.23M
MDSO
11
DELISTED
Medidata Solutions, Inc.
MDSO
$5.63M 2.5%
+62,256
New +$5.46M
FDC
12
DELISTED
First Data Corporation
FDC
$5.37M 2.39%
198,417
+27,817
+16% +$724K
DATA
13
DELISTED
Tableau Software, Inc.
DATA
$5.23M 2.32%
+31,491
New +$4.14M
MLNX
14
DELISTED
Mellanox Technologies, Ltd.
MLNX
$4.98M 2.21%
45,000
+15,000
+50% +$1.73M
TAK icon
15
Takeda Pharmaceutical
TAK
$54.4B
$4.96M 2.2%
280,000
-150,369
-35% -$2.74M
WP
16
DELISTED
Worldpay, Inc.
WP
$4.89M 2.17%
39,880
+8,300
+26% +$984K
EFII
17
DELISTED
Electronics for Imaging
EFII
$4.24M 1.89%
+115,000
New +$4.11M
ARRY
18
DELISTED
Array Biopharma Inc
ARRY
$4.17M 1.85%
+90,000
New +$2.53M
VSM
19
DELISTED
Versum Materials, Inc.
VSM
$4.13M 1.83%
+80,000
New +$4.13M
ALXN
20
DELISTED
Alexion Pharmaceuticals
ALXN
$3.55M 1.58%
+27,078
New +$3.49M
PFE icon
21
Pfizer
PFE
$143B
$3.46M 1.54%
84,173
+4,995
+6% +$198K
MRK icon
22
Merck
MRK
$314B
$3.42M 1.52%
42,790
+11,591
+37% +$888K
GILD icon
23
Gilead Sciences
GILD
$167B
$3.38M 1.5%
50,013
+2,013
+4% +$132K
AGN
24
DELISTED
Allergan plc
AGN
$3.35M 1.49%
+20,000
New +$2.77M
FE icon
25
FirstEnergy
FE
$28.1B
$3.11M 1.38%
72,639

Similar funds

Exane Asset Management's Q2 2019 Portfolio in Review

As of Q2 2019, Exane Asset Management held 65 positions worth $225M, up 9.5% from $206M the previous quarter. Its ten largest holdings account for 53% of the portfolio.

Exane Asset Management deployed $21.9M of net new capital in Q2 2019, opening 24 new positions and adding to 14 existing holdings. Its largest new stake was Ashland: 233,279 shares worth $18.7M.

By sector, the portfolio is most concentrated in Healthcare at 30% of assets, up from 25% a quarter earlier, followed by Materials and Communication Services.

On the sell side, the largest reduction was TIM SA, an estimated $5.23M trimmed.

  • Exane Asset Management's largest Q2 2019 buy was Ashland: 233,279 shares worth $18.7M.
  • Exane Asset Management added most to DuPont de Nemours in Q2 2019, an estimated $11.3M increase.
  • Exane Asset Management's biggest Q2 2019 reduction was TIM SA, cutting an estimated $5.23M.
  • Exane Asset Management fully exited PPG Industries in Q2 2019, selling an estimated $15M.
  • Exane Asset Management's ten largest holdings make up 53% of its $225M portfolio in Q2 2019.
  • Exane Asset Management opened 24 new positions and closed 15 in Q2 2019.
  • Exane Asset Management's portfolio value rose 9.5% quarter-over-quarter to $225M.

Based on Exane Asset Management's 13F filing for Q2 2019, filed 5 Aug 2019.